Navigation Links
Ben-Gurion University of the Negev receives $450,000 grant to conduct oil and natural gas research
Date:8/8/2012

BEER-SHEVA, ISRAEL, August 8, 2012 Ben-Gurion University of the Negev (BGU) researchers have received a $450,000 grant (290,000) from the Wolfson Family Charitable Trust and Wolfson Foundation for projects related to oil and gas generation and its environmental impact.

According to BGU's Vice President for Research and Development Prof. Moti Herskowitz, these two projects are part of the University's overall commitment to research alternative energy sources and cleaner technologies. "This support reflects BGU's leadership role in alternative energy research in Israel thanks to its multidisciplinary approach," says Herskowitz, who is also the founder and director of the BGU Blechner Center for Industrial Catalysis and Process Development.

One of the grant projects being conducted at the Blechner Center is focused on using a novel method for conversion of natural gas to syngas through catalytic partial oxidation for downstream treatment of natural gas. The researchers believe that this process provides significant opportunities for commercial production.

The other project involves tracking oil and gas formation in a variety of environments, source rocks and generation mechanisms, through the investigation of sulfur and short hydrocarbon transformations using molecular and isotopic geochemical approach. The research will be conducted by BGU's Department of Geology and Environmental Sciences to help improve the understanding of oil and gas generation and their environmental impact.

"BGU has a worldwide reputation for its research and innovation in alternative energy, and now, this grant will further Israel's position in reducing worldwide reliance on oil, as part of the BGU energy initiative," says Doron Krakow, executive vice president of American Associates, Ben-Gurion University of the Negev.


'/>"/>

Contact: Andrew Lavin
andrewlavin@alavin.com
516-944-4486
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Page: 1

Related biology news :

1. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
2. Sleep deprivation may reduce risk of PTSD according to Ben-Gurion U. researchers
3. University of Houston study shows BP oil spill hurt marshes, but recovery possible
4. University of Alberta led research may have discovered how memories are encoded in our brains
5. BGI, University of Helsinki and Wuhan University sign a MOU concerning cooperation on genomics
6. Marshall University study may lead to new treatments for prostate cancer
7. University leads £6 million EU project to tackle obesity
8. A University of Tennessee professors hypothesis may be game changer for evolutionary theory
9. Life expectancy may affect when you get married, divorced, have kids: Queens University study
10. University of Toronto biologists predict extinction for organisms with poor quality genes
11. University of Minnesota invention helps advance reliability of alternative energy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2014)... – University of Utah engineers developed the first room-temperature ... produce electricity without needing to ignite the fuel. These ... electronics, off-grid power and sensors. , A study of ... Chemical Society journal ACS Catalysis . , Fuel ... between a fuel and an oxygen-rich source such as ...
(Date:11/4/2014)...   3D scanner ... Fuel3D , a developer of 3D scanning solutions, ... $6.4 million (£4 million). This funding builds on the company,s ... and paves the way for the commercial launch of the ... round was led by Chimera Partners and will be used ...
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® , ... life sciences company focused on commercialization of its ... for the treatment of neurological and neuropsychiatric disorders, ... Property has issued a Notice of Allowance for ... is co-owned by NeuroSigma and the Regents of ...
Breaking Biology News(10 mins):Jet-fueled electricity at room temperature 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... Although the soluble factor TGF-beta has been shown to suppress ... breast cancer, high levels of TGF-beta during the later stages ... study using human breast cancer samples and mice, which appears ... January print issue of the Journal of Clinical Investigation, indicates ...
... successfully tested two candidate vaccines that may eventually be ... Their findings are published in the December 15 issue ... , Barney S. Graham, MD, PhD, and colleagues from ... in Maryland, the Fred Hutchinson Cancer Research Center in ...
... the University of Rochester may have answered one of ... neurons, which are responsible for our crystal-clear thoughts, seem ... November issue of Nature Neuroscience, the Rochester study shows ... signals to represent the ambiguities of the real world--and ...
Cached Biology News:Progress made in HIV vaccine development 2Mysterious 'neural noise' actually primes brain for peak performance 2Mysterious 'neural noise' actually primes brain for peak performance 3
(Date:11/26/2014)... November 25, 2014 Silicon Valley Electronic ... with RPM Alliance , provider of clinical research ... With the latest addition to its CRO Partnership Program, ... EDC system to India. , “We have found ... and customizable EDC platform which is both user friendly ...
(Date:11/26/2014)... SoundConnect , an award winning ... announce that Darren Suders has joined the team as ... drive the partner program through innovative offerings, ... , Darren brings more than 10-years of channel telecommunication ... channel operations, from policy development, to partner education and ...
(Date:11/26/2014)... -- Theravalues Corporation annuncia con orgoglio il lancio di ... Hi Europe 2014 (dal 2 al 4 dicembre, ... curcumina con la maggiore biodisponibilità di sempre, con una ... dalle norme europee. La curcumina è un ... Curcuma longa ) che è stata associata con attività ...
(Date:11/24/2014)... , Nov. 24, 2014 VolitionRx Limited ... tests for cancer and other conditions, today announced that data ... the Science for Business BioWin Day 2014, being held November ... data come from VolitionRx,s lung cancer pilot study, the samples ... Centre Hospitalier Universitaire (CHU) de Liege in Belgium ...
Breaking Biology Technology:RPM Alliance Joins Clinovo’s CRO Partnership Program, Further Strengthening Its Presence in Southern California and India 2SoundConnect Appoints Director of Channel Development & Sales 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 2La curcumina con la maggiore biodisponibilità di sempre farà il suo debutto in Europa 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 2VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 3VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 4VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 5VolitionRx to Present Positive Data from Pilot Lung Cancer Study at BioWin Day 2014 6
... Calif., Jan. 22 Abaxis, Inc.,(Nasdaq: ABAX ), ... scheduled a conference call to discuss its,financial results for ... 2007. The call will be at 4:15 p.m. ET, ... 356-5706 or (706) 643-0580 to access the,conference call, or ...
... 8:30 a.m. EST at ... http://www.isispharm.com , ... ) announced today that Abbott is,investing up to $40 million in ... further develop the Ibis T5000(TM),Biosensor System, which offers a unique solution ...
... Marker Precision and ... Simultaneous Diagnostic Monitoring MUKILTEO, Wash. ... CBMX ) and Clarient, Inc. (Nasdaq: CLRT ),today ... a novel genomics-based cancer test called HemeScan(TM), a,comprehensive test related ...
Cached Biology Technology:Abaxis to Report Third Quarter Fiscal 2008 Financial Results Thursday, January 31, 2008 2Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity 2Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity 3Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity 4CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL) 2CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL) 3CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL) 4CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL) 5CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL) 6
Mouse BLC/BCA 1 - 10kDa...
Bag-1 (K-20)...
... PGE2-d4 contains 4 deuterium atoms at ... It is intended for use as an ... E2 (PGE2) by GC- or LC-mass spectrometry. ... products of arachidonic acid and one of ...
Deletions, insertions or substitutions. Mutations in plasmids of size up to 15 kb. Single or multiple mutations...
Biology Products: